drug

valacyclovir

1 story · latest Aug 13, 2026

Status: FDA approved Jun 1995 · NDA020487, NDA020550
Brand: Valtrex
Trials: 1 registered trial in coverage

Relationships

Developed by GlaxoSmithKline

Also known as

valacyclovir hydrochloride

Timeline

Candel targets Q4 2026 BLA for prostate cancer therapy, opens NSCLC phase 3 trial

Aug 13Quarterly updateCandel Therapeutics, Inc.

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.